G

Genex Pharmaceutical
GENX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$3.57K
EV
-
Shares Outstanding
17.88M
Beta
-56.61
Industry
Drug Manufacturers - Specialty & Generic

Wall Street View

Analyst Rating
-
Analyst Target Price
-
Number of Analysts
0
P/E E
-
P/Revenue E
-

Historical 3Y Growth Rate

Revenue
-
EPS
-
Operating Cash Flow
-
Free Cash Flow
-

Forecasted 3Y Growth Rate

Revenue
-
EPS
-
Operating Cash Flow
-
Free Cash Flow
-

Margins & Returns

Gross Margin E
-
Net Profit Margin E
-
ROE E
-
ROCE
-

Dividends

DPS E
-
Payout Ratio E
-
Div. Yield E
-
DPS Last 3Y CAGR
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Genex Pharmaceutical, Inc.

gainify

G

Genex Pharmaceutical, Inc.

GENX

Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People’s Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as ...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Song, Fuzhi

Employees

86

IPO Date

2004-03-29

Headquarters

1801 Guangyin Building, Youyibeilu Hexi District, Tianjin 300074, China

📊 Stock Price & Performance

Review of Recent GENX Stock Performance trends:Past 1 Month: Genex Pharmaceutical (GENX) shares changed by +100.00%.Past 3 Months: The stock recorded a change of +100.00%.Past 6 Months: GENX shares posted a change of +100.00%. Last updated: March 7, 2026 at 10:52 PM Eastern Time

Over the last year, Genex Pharmaceutical (GENX) has established a 52-week price range between a high of $0.00 and a low of $0.00. This metric is essential for assessing the stock's annual volatility. Last updated: March 7, 2026 at 10:52 PM Eastern Time

Genex Pharmaceutical (GENX) is considered a low volatility stock. It has a beta of -56.61, which means it typically moves in the opposite direction of the broader market, with a magnitude of approximately 56.61 times the market's movement. Over the past 52 weeks, GENX has traded within a $0.00 – $0.00 range. Last updated: March 7, 2026 at 10:52 PM Eastern Time

💰 Financial Metrics & Reports

The current Genex Pharmaceutical (GENX) market capitalization is approximately $3.57K, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Genex Pharmaceutical's market cap fluctuates with changes in its share price and share count. Last updated: March 7, 2026 at 10:52 PM Eastern Time

📅 Earnings & Dividends

Genex Pharmaceutical (GENX) does not currently pay a dividend. Over the last twelve months (LTM), the company paid $0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future.

📈 Analyst Information

Based on the latest available analyst coverage, Genex Pharmaceutical (GENX) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice.

Like other publicly traded stocks, Genex Pharmaceutical (GENX) shares are bought and sold on stock exchanges such as OTCPK and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Genex Pharmaceutical (GENX) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

ℹ️ Company Information

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add GENX to your watchlist.

Genex Pharmaceutical trades under the ticker symbol GENX on the OTCPK stock exchange. The ticker GENX is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

As of the most recently reported period, Genex Pharmaceutical (GENX) employs approximately 86 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: March 7, 2026 at 10:52 PM Eastern Time

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
© 2026 Gainify. All rights reserved.